Cadence Design Systems, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cadence Design Systems, Inc. (CDNS) on November 17, 2025. The report discloses a corporate governance event regarding the appointment of a new director to the Board of Directors.
Key Financial Metrics
The filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial figure disclosed relates to director compensation: an equity award with a grant date fair value of $82,849.
Material Changes
The primary material change reported is the appointment of Dr. Luc Van den hove as a director, effective January 1, 2026. No financial or operational changes versus prior periods are detailed in this document.
Management Commentary and Governance Details
- Appointment: Dr. Luc Van den hove was appointed to the Board effective January 1, 2026. Committee assignments have not yet been determined.
- Compensation: Dr. Van den hove will receive an equity award under the 1995 Directors Stock Incentive Plan valued at $82,849. The award vests on the earlier of May 8, 2026, or the 2026 annual meeting, contingent on continued service. Cash compensation will align with other non-employee directors.
- Background: Dr. Van den hove has served as President and CEO of imec since 2009. He will continue in this role through March 31, 2026, before transitioning to Chair of imec's board on April 1, 2026. He also serves as a director of Proximus plc.
- Risks and Contingencies: The filing does not disclose new risks or contingencies beyond standard indemnification agreements.
Investor Verification Checklist
- Verify the effective date of Dr. Van den hove's board appointment (January 1, 2026).
- Confirm the vesting schedule of the $82,849 equity award (earlier of May 8, 2026, or the 2026 annual meeting).
- Review the definitive proxy statement filed on March 25, 2025, for details on standard non-employee director cash compensation.
- Monitor future filings for Dr. Van den hove's specific committee assignments.